Medicover AB (publ) (FRA:5M0B)

Medicover AB Statistics

Total Valuation

Medicover AB has a market cap or net worth of EUR 3.23 billion. The enterprise value is 4.60 billion.

Market Cap	3.23B
Enterprise Value	4.60B

Important Dates

The last earnings date was Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	Apr 30, 2025

Share Statistics

Current Share Class	74.43M
Shares Outstanding	n/a
Shares Change (YoY)	+0.46%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	11.17%
Owned by Institutions (%)	26.66%
Float	50.90M

Valuation Ratios

The trailing PE ratio is 48.05 and the forward PE ratio is 32.86.

PE Ratio	48.05
Forward PE	32.86
PS Ratio	1.39
PB Ratio	6.21
P/TBV Ratio	n/a
P/FCF Ratio	19.49
P/OCF Ratio	10.51
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.35, with an EV/FCF ratio of 27.72.

EV / Earnings	68.32
EV / Sales	1.97
EV / EBITDA	13.35
EV / EBIT	27.96
EV / FCF	27.72

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 2.74.

Current Ratio	0.78
Quick Ratio	0.68
Debt / Equity	2.74
Debt / EBITDA	4.17
Debt / FCF	8.60
Interest Coverage	2.58

Financial Efficiency

Return on equity (ROE) is 11.98% and return on invested capital (ROIC) is 5.63%.

Return on Equity (ROE)	11.98%
Return on Assets (ROA)	4.64%
Return on Invested Capital (ROIC)	5.63%
Return on Capital Employed (ROCE)	9.41%
Revenue Per Employee	49,409
Profits Per Employee	1,432
Employee Count	47,256
Asset Turnover	1.06
Inventory Turnover	28.16

Taxes

In the past 12 months, Medicover AB has paid 24.50 million in taxes.

Income Tax	24.50M
Effective Tax Rate	28.06%

Stock Price Statistics

The stock price has increased by +34.41% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.41%
50-Day Moving Average	22.47
200-Day Moving Average	21.73
Relative Strength Index (RSI)	33.30
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicover AB had revenue of EUR 2.32 billion and earned 67.30 million in profits. Earnings per share was 0.45.

Revenue	2.32B
Gross Profit	534.30M
Operating Income	163.10M
Pretax Income	87.30M
Net Income	67.30M
EBITDA	248.10M
EBIT	163.10M
Earnings Per Share (EPS)	0.45

Balance Sheet

The company has 85.50 million in cash and 1.43 billion in debt, giving a net cash position of -1.34 billion.

Cash & Cash Equivalents	85.50M
Total Debt	1.43B
Net Cash	-1.34B
Net Cash Per Share	n/a
Equity (Book Value)	521.10M
Book Value Per Share	3.36
Working Capital	-133.90M

Cash Flow

In the last 12 months, operating cash flow was 307.80 million and capital expenditures -141.90 million, giving a free cash flow of 165.90 million.

Operating Cash Flow	307.80M
Capital Expenditures	-141.90M
Free Cash Flow	165.90M
FCF Per Share	n/a

Margins

Gross margin is 23.01%, with operating and profit margins of 7.02% and 2.90%.

Gross Margin	23.01%
Operating Margin	7.02%
Pretax Margin	3.76%
Profit Margin	2.90%
EBITDA Margin	10.68%
EBIT Margin	7.02%
FCF Margin	7.14%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.74%.

Dividend Per Share	0.15
Dividend Yield	0.74%
Dividend Growth (YoY)	25.00%
Years of Dividend Growth	n/a
Payout Ratio	33.43%
Buyback Yield	-0.46%
Shareholder Yield	0.28%
Earnings Yield	2.08%
FCF Yield	5.13%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medicover AB has an Altman Z-Score of 2.2 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	7